Fruth Investment Management Bristol Myers Squibb CO Transaction History

Fruth Investment Management

$385 Million
Q3 2024

A detailed history of Fruth Investment Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fruth Investment Management holds 16,130 shares of BMY stock, worth $949,573. This represents 0.22% of its overall portfolio holdings.

Number of Shares

16,130

Previous 16,280 0.92%

Holding current value

$949,573

Previous $676,000 23.37%

% of portfolio

0.22%

Previous 0.18%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$39.66 - $51.75 $5,948 - $7,762	-150 Reduced 0.92%	16,130 $834,000
Q2 2024 Jul 18, 2024	SELL	$40.25 - $52.99 $6,037 - $7,948	-150 Reduced 0.91%	16,280 $676,000
Q1 2024 Apr 19, 2024	BUY	$47.98 - $54.4 $4,798 - $5,440	100 Added 0.61%	16,430 $890,000
Q4 2023 Jan 18, 2024	BUY	$48.48 - $57.85 $8,726 - $10,413	180 Added 1.11%	16,330 $837,000
Q2 2023 Jul 25, 2023	SELL	$63.71 - $70.74 $6,371 - $7,073	-100 Reduced 0.62%	16,150 $1.03 Million
Q1 2023 Apr 26, 2023	SELL	$65.71 - $74.53 $15,376 - $17,440	-234 Reduced 1.42%	16,250 $1.13 Million
Q4 2022 Jan 17, 2023	SELL	$68.48 - $81.09 $17,120 - $20,272	-250 Reduced 1.49%	16,484 $1.19 Million
Q3 2022 Oct 13, 2022	SELL	$0.13 - $76.84 $6 - $3,842	-50 Reduced 0.3%	16,734 $1.19 Million
Q3 2021 Oct 12, 2021	SELL	$59.17 - $69.31 $414 - $485	-7 Reduced 0.04%	16,784 $993,000
Q2 2021 Jul 19, 2021	BUY	$61.91 - $67.42 $33,183 - $36,137	536 Added 3.3%	16,791 $1.12 Million
Q1 2021 Apr 14, 2021	SELL	$59.34 - $66.74 $21,362 - $24,026	-360 Reduced 2.17%	16,255 $1.03 Million
Q4 2020 Jan 13, 2021	SELL	$57.74 - $65.43 $25,983 - $29,443	-450 Reduced 2.64%	16,615 $1.03 Million
Q3 2020 Oct 07, 2020	SELL	$57.43 - $63.64 $28,715 - $31,820	-500 Reduced 2.85%	17,065 $1.03 Million
Q2 2020 Jul 13, 2020	SELL	$54.82 - $64.09 $10,964 - $12,818	-200 Reduced 1.13%	17,565 $1.03 Million
Q1 2020 Apr 29, 2020	SELL	$46.4 - $67.43 $9,280 - $13,486	-200 Reduced 1.11%	17,765 $990,000
Q4 2019 Jan 10, 2020	BUY	$49.21 - $64.19 $16,337 - $21,311	332 Added 1.88%	17,965 $1.15 Million
Q3 2019 Oct 09, 2019	SELL	$42.77 - $50.71 $14,969 - $17,748	-350 Reduced 1.95%	17,633 $894,000
Q2 2019 Jul 15, 2019	SELL	$44.62 - $49.34 $11,155 - $12,335	-250 Reduced 1.37%	17,983 $815,000
Q4 2018 Jan 16, 2019	SELL	$48.76 - $63.23 $19,504 - $25,292	-400 Reduced 2.15%	18,233 $947,000
Q2 2018 Jul 23, 2018	SELL	$50.53 - $62.98 $25,265 - $31,490	-500 Reduced 2.61%	18,633 $1.03 Million
Q1 2018 May 01, 2018	SELL	$59.92 - $68.98 $35,952 - $41,388	-600 Reduced 3.04%	19,133 $1.21 Million
Q3 2017 Oct 12, 2017	BUY	$55.23 - $63.74 $1.09 Million - $1.26 Million	19,733	19,733 $1.26 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fruth Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Fruth Investment Management with notifications on news.

Account

Fruth Investment Management Bristol Myers Squibb CO Transaction History